FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2016/02/006644 [Registered on: 16/02/2016] Trial Registered Retrospectively
Last Modified On: 16/11/2019
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Cohort Study 
Study Design  Other 
Public Title of Study   To study Mucormycosis epidemiology in India 
Scientific Title of Study   Multicenter observational study on epidemiology, treatment and outcome of Mucormycosis in India 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Atul K Patel 
Designation  Consultant Physician, Infectious Diseases 
Affiliation  Fungal Infection Study Forum 
Address  3rd Floor, Vedanta Inst of Med Sciences, Navarangpura. Ahmedabad.
A-703, Lovely Apartment, Plot No 5, Sector-5, Dwarka, New Delhi
Ahmadabad
GUJARAT
380009
India 
Phone  07926440816  
Fax    
Email  atulpatel65@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Atul K Patel 
Designation  Consultant Physician, Infectious Diseases 
Affiliation  Fungal Infection Study Forum 
Address  3rd Floor, Vedanta Inst of Med Sciences, Navarangpura. Ahmedabad.
A-703, Lovely Apartment, Plot No 5, Sector-5, Dwarka, New Delhi
Ahmadabad
GUJARAT
380009
India 
Phone  07926440816  
Fax    
Email  atulpatel65@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Atul K Patel 
Designation  Consultant Physician, Infectious Diseases 
Affiliation  Fungal Infection Study Forum 
Address  3rd Floor, Vedanta Inst of Med Sciences, Navarangpura. Ahmedabad.
A-703, Lovely Apartment, Plot No 5, Sector-5, Dwarka, New Delhi
Ahmadabad
GUJARAT
380009
India 
Phone  07926440816  
Fax    
Email  atulpatel65@gmail.com  
 
Source of Monetary or Material Support  
Mylan Pharmaceuticals Private Limited 
 
Primary Sponsor  
Name  MYLAN PHARMACEUTICALS PRIVATE LIMITED  
Address  10th Floor,Prestige Platina, Block 3,Kadubeesanahalli Village,Varthur Hobli, Outer Ring Road, Bangalore 560087  
Type of Sponsor  Pharmaceutical industry-Indian 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 17  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Immaculata Xess  All India Institute of Medical Sciences  Department of Microbiology All India Institute of Medical Sciences, New Delhi, 110029
New Delhi
DELHI 
9818268181

immaxess@gmail.com 
Dr Raman Sardana   Apollo Hospital  Indraprastha Apollo Hospitals, Sarita Vihar, Delhi - Mathura Road, New Delhi - 110076
New Delhi
DELHI 
9811057511

ramansardana@apollohospitals.com 
Dr Joy Sarojini Michael   Christian Medical College  Department of Microbiology Christian Medical College Vellore 632004 Tamil Nadu , India
Vellore
TAMIL NADU 
0416-2282588

joymichael@cmcvellore.ac.in 
Dr Sangeetha Mohan  Christian Medical College and Hospital,  Christian Medical College and Hospital, Brown Road Ludhiana, Punjab PIN: 141008
Ludhiana
PUNJAB 
01612115782

drsangmohan@gmail.com 
Dr Ranganathan Iyer  Global Hospital   Department of Clinical Microbiology Global Hospital Near District Collectors office Lakdi- ka- pul Hyderabad Pin- 500004
Hyderabad
ANDHRA PRADESH 
040-23244444

ranganathaniyer@yahoo.com 
Dr Rajeev Soman   Hinduja Hospital  PD Hinduja National Hospital and Medical Research centre Veer Savarkar Marg Mahim Mumbai 400016
Mumbai
MAHARASHTRA 
9892024799

rajeev.soman@yahoo.com 
Dr Rakesh Singh  JIPMER  Department of Microbiology, JIPMER, Pondicherry 605006
Pondicherry
PONDICHERRY 
9751173425

drrakesh1976@yahoo.com 
Dr Peralam Yegneswaran Prakash  Kasturba Medical College - Manipal  Department of Microbiology, Medical Mycology Laboratory, II floor, Center for Basic Sciences Building, Kasturba Medical College - Manipal, Manipal University, Madhav Nagar, Manipal, Udupi District, Karnataka State, INDIA - Pincode: 576 104
Udupi
KARNATAKA 
08202922322

prakashpy123@yahoo.co.in 
Dr P Umabala  Nizams Institute Of Medical Sciences  Nizams Institute Of Medical Sciences Panjagutta, Hyderabad Telengana state PIN-500082

 
9010151200

umapamidi@gmail.com 
Dr Arunaloke Chakrabarti  PGIMER  PGIMER, Chandigarh
Chandigarh
CHANDIGARH 
0172274990

arunaloke@hotmail.com 
Dr Malini R Capoor  Safdarjung Hospital  VMMC and Safdarjung Hospital, Delhi
New Delhi
DELHI 
01126165032

rajeevmalini@rediffmail.com 
Dr Arvind Baronia  SGPGIMS  SGPGIIMS Rae Bareli Road, Lucknow, Uttar Pradesh 226014
Lucknow
UTTAR PRADESH 
0522-2494479

arvindbaronia@hotmail.com 
Dr Prakash S Shastri  Sir Gangaram Hospital  Sir Gangaram Hospital, Rajinder Nagar, New Delhi. 110060
New Delhi
DELHI 
9810937295

prakashshastri@live.in 
Dr Anupma Lakra  Sri Ramachandra Medical College   Professor, Dept of Microbiology, Sri Ramachandra Medical College & RI, Porur, Chennai - 600116
Chennai
TAMIL NADU 
044-24768403

anupmalakra@gmail.com 
Dr Jayanthi Savio  St Johns Medical College Hospital  St.Johns Medical College Hospital, Sarjapur Road, Bangalore 560034
Bangalore
KARNATAKA 
08049466253

jayanthisjmc@gmail.com 
Dr Atul K Patel  Sterling Hospital  Sterling Hospital, Off Gurukul Road. Memnagar. Ahmedabad
Ahmadabad
GUJARAT 
07926440816

atulpatel65@gmail.com 
Dr Sanjay K Biswas  Tata Memorial Hospital  Dept of Microbiology, 6th Floor, Annexe Bldg, Tata Memorial Hospital, E. Borges Rd, Parel, Mumbai-400012.
Mumbai
MAHARASHTRA 
02224177098

skbiswas67@rediffmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 17  
Name of Committee  Approval Status 
Institutional Ethics Committee (IEC) of SGPGIMS  Approved 
CMC Ludhiana  Approved 
Ethics Committee on Clinical Trials, Indraprastha Apollo Hospital  Submittted/Under Review 
Ethics Committee Sir Gangaram Hospital  Submittted/Under Review 
INSTITUTE ETHICS COMMITTEE ALL INDIA INSTITUTE OF MEDICAL SCIENCES  Submittted/Under Review 
Institute ethics committee, PGIMER  Submittted/Under Review 
Institutional Ethics Committee, Global Hospital, Hyderabad  Submittted/Under Review 
IRB CMC Vellore  Approved 
JIPMER Institute Ethics Committee (IEC)-Human Studies  Submittted/Under Review 
KASTURBA MEDICAL COLLEGE & KASTURBA HOSPITAL, MANIPAL INSTITUTIONAL ETHICS COMMITTEE   Submittted/Under Review 
NIMS Institutional Ethics committee  Approved 
P. D. Hinduja Hospital and Medical Research Center  Submittted/Under Review 
Sri Ramchandra University  Approved 
St Johns National Academy of Health Science Institutional EC  Approved 
Sterling Hospital Ethics Committee  Approved 
Tata Memorial Hospital IRB  Submittted/Under Review 
VMMC and Safdarjung Hospital Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied
Modification(s)  
Health Type  Condition 
Patients  Patients who diagnosed with Mucormycosis, (1) ICD-10 Condition: B46||Zygomycosis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  1.00 Day(s)
Age To  80.00 Year(s)
Gender  Both 
Details  Any age group of patients with confirmed & probable diagnosis of Mucormycosis will be enrolled for this study 
 
ExclusionCriteria 
Details  Any subject without a confirmed diagnosis of mucormycosis. 
 
Method of Generating Random Sequence    
Method of Concealment    
Blinding/Masking    
Primary Outcome  
Outcome  TimePoints 
1.Overall survival at 45 and 90 days
2.Cure: defined as complete resolution of clinical, radiological and mycological evidence
3.Improved: Resolution of clinical features, radiological regression
outcome of mucormycosis in India 
45 and 90 days 
 
Secondary Outcome  
Outcome  TimePoints 
Grade III and IV toxicities of antifungal agents  45 days 
 
Target Sample Size   Total Sample Size="300"
Sample Size from India="300" 
Final Enrollment numbers achieved (Total)= "465"
Final Enrollment numbers achieved (India)="465" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/01/2016 
Date of Study Completion (India) 31/12/2017 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

Study Summary

Title

Multicenter observational study on epidemiology, treatment and outcome of  Mucormycosis in India

Short Title

Description of epidemiology, treatment practice and outcome of mucomycosis in India

Protocol Number

FISF 001.3

Phase

IV

Methodology

Observational study

Study Duration

1  years

Study Center(s)

Multi-center.

Objectives

Primary:

- To describe the epidemiology, diagnosis, treatment practices and outcome of mucormycosis in India

 

Secondary:

-          Sites involved in mucormycosis

-          Underlying disease and risk factors for mucormycosis

-          Spectrum of agents causing mucormycosis

–        mode of diagnosis of mucormycosis

 

Number of Subjects

At least 300

Diagnosis and Main Inclusion Criteria

Proven and probable cases of mucormycosis

Study Product, Dose, Route, Regimen

No study product will be used as it is only observational study

Duration of administration

not applicable

Reference therapy

Not applicable

Statistical Methodology

Descriptive and quantitative statistics

 
Close